stockrowThe Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Return on assets
The Chemours Company's return on assets over the twelve months to 30 September 2026 was −2.07%, up 3.1 percentage points from fiscal 2025 (−5.18%). Over the past ten years it has ranged from −5.18% (fiscal 2025) to 13.6% (fiscal 2018) — the current reading is the lowest in ten years. That is below the Specialty Chemicals industry median of 0.45% and below the Basic Materials sector median of 0.00%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −5.18% | (6.06) |
| FY2024 | 0.88% | 4.06 |
| FY2023 | −3.18% | (10.79) |
| FY2022 | 7.61% | (0.70) |
| FY2021 | 8.31% | 5.26 |
| FY2020 | 3.05% | 3.76 |
| FY2019 | −0.71% | (14.29) |
| FY2018 | 13.6% | 2.41 |
| FY2017 | 11.2% | 11.06 |
| FY2016 | 0.11% | 1.58 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| WDFC WD-40 Company compare | 16.9% |
| IOSP Innospec Inc. compare | 7.68% |
| FUL H. B. Fuller Company compare | 3.73% |
| KWR Quaker Houghton compare | 3.39% |
| NGVT Ingevity Corporation compare | 3.16% |
| SCL Stepan Company compare | 0.18% |
| MTX Minerals Technologies Inc. compare | −1.93% |
| CC The Chemours Company | −2.07% |
| STDN Standard Nuclear Inc compare | — |
| Specialty Chemicals industry median | 0.45% |
| Basic Materials sector median | 0.00% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement